Dr. Cameron Ghaffary, M.D.
What this data tells you about Dr. Ghaffary
Dr. Cameron Ghaffary is a surgery in Galveston, TX, with 11 years in practice. Based on federal Medicare data, Dr. Ghaffary performed 4,159 Medicare services across 2,562 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghaffary received a total of $6,708 from 29 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghaffary is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis test with examination using microscope, non-automated | 1,008 | $4 | $25 |
| Bladder ultrasound after voiding | 678 | $8 | $31 |
| Office visit, established patient (30-39 min) | 610 | $89 | $370 |
| Office visit, established patient (20-29 min) | 406 | $63 | $257 |
| Blood draw (venipuncture) | 234 | $8 | $15 |
| PSA test (prostate cancer screening) | 229 | $18 | $105 |
| Ceftriaxone antibiotic injection | 208 | $0 | $30 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 204 | $130 | $750 |
| New patient office visit (45-59 min) | 119 | $118 | $482 |
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $184 | $683 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 53 | $675 | $2,464 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 47 | $25 | $98 |
| Simple insertion of temporary bladder tube | 33 | $46 | $178 |
| Insertion of temporary bladder tube | 28 | $32 | $129 |
| Testosterone (hormone) level, free | 28 | $25 | $35 |
| Simple measurement of pressure of urine flow in bladder | 27 | $163 | $650 |
| Ultrasound scan of pelvic region through rectum | 23 | $98 | $539 |
| New patient office visit (30-44 min) | 23 | $78 | $324 |
| Insertion of stent in ureter using an endoscope | 16 | $93 | $524 |
| Biopsy of prostate gland | 16 | $176 | $698 |
| Shock wave crushing of kidney stones | 15 | $414 | $1,776 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $551 | $2,091 |
| Electronic assessment of bladder emptying | 13 | $6 | $37 |
| Office visit, established patient (10-19 min) | 12 | $37 | $162 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 11 | $940 | $3,610 |
| Initial hospital admission, moderate complexity | 11 | $102 | $359 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ghaffary is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ghaffary experienced with manual urinalysis test with examination using microscope, non-automated?
Does Dr. Ghaffary receive payments from pharmaceutical companies?
How do Dr. Ghaffary's costs compare to other surgerys in Galveston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology